Next Article in Journal
Study of the Influence of NanOx Parameters
Next Article in Special Issue
Curcuminoids as EBV Lytic Activators for Adjuvant Treatment in EBV-Positive Carcinomas
Previous Article in Journal
Role of Pattern Recognition Receptors in KSHV Infection
Previous Article in Special Issue
Epstein–Barr Virus Gene BARF1 Expression is Regulated by the Epithelial Differentiation Factor ΔNp63α in Undifferentiated Nasopharyngeal Carcinoma
Article Menu
Issue 4 (April) cover image

Export Article

Open AccessFeature PaperReview
Cancers 2018, 10(4), 86;

New Insights from Elucidating the Role of LMP1 in Nasopharyngeal Carcinoma

Cancer Virology Program, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA
Department of Microbiology and Molecular Genetics, and Center for Evolutionary Biology and Medicine, University of Pittsburgh, Pittsburgh, PA 15219, USA
Author to whom correspondence should be addressed.
Received: 3 March 2018 / Revised: 16 March 2018 / Accepted: 20 March 2018 / Published: 21 March 2018
(This article belongs to the Special Issue Epstein–Barr Virus Associated Cancers)
PDF [1168 KB, uploaded 3 May 2018]


Latent membrane protein 1 (LMP1) is an Epstein-Barr virus (EBV) oncogenic protein that has no intrinsic enzymatic activity or sequence homology to cellular or viral proteins. The oncogenic potential of LMP1 has been ascribed to pleiotropic signaling properties initiated through protein-protein interactions in cytosolic membrane compartments, but the effects of LMP1 extend to nuclear and extracellular processes. Although LMP1 is one of the latent genes required for EBV-immortalization of B cells, the biology of LMP1 in the pathogenesis of the epithelial cancer nasopharyngeal carcinoma (NPC) is more complex. NPC is prevalent in specific regions of the world with high incidence in southeast China. The epidemiology and time interval from seroconversion to NPC onset in adults would suggest the involvement of multiple risk factors that complement the establishment of a latent and persistent EBV infection. The contribution of LMP1 to EBV pathogenesis in polarized epithelia has only recently begun to be elucidated. Furthermore, the LMP1 gene has emerged as one of the most divergent sequences in the EBV genome. This review will discuss the significance of recent advances in NPC research from elucidating LMP1 function in epithelial cells and lessons that could be learned from mining LMP1 sequence diversity. View Full-Text
Keywords: Epstein-Barr virus; LMP1; epithelial infection; nasopharyngeal carcinoma Epstein-Barr virus; LMP1; epithelial infection; nasopharyngeal carcinoma

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Shair, K.H.Y.; Reddy, A.; Cooper, V.S. New Insights from Elucidating the Role of LMP1 in Nasopharyngeal Carcinoma. Cancers 2018, 10, 86.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top